CANCER
THE IMPACT OF A CANCER SCREENING PROGRAM ON UNCERTAINTY, ANTİCİPATORY ANXIETY, CANCER AWARENESS, AND E-HEALTH LITERACY IN A GROUP OF STROKE PATIENTS
Sponsor study identifier
interventional
88
1 country
1
Study Start
January 1, 2025
Actual (reported)Primary Completion
January 1, 2026
Actual (reported)Study Completion
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This research aims to evaluate the impact of a cancer awareness education program (Cancer Awareness Programme Via Digital Health Literacy - DigiCAP), designed to enhance digital literacy and applied to stroke patients, on uncertainty, anticipatory anxiety, and cancer awareness. This study was designed as a randomized controlled, single-blind (evaluator-blind), pre-test-post-test experimental design. In the study, all individuals in the sample group were administered the Personal Information Form, the Mishel Illness Uncertainty Scale-Community Form (MIIS-T), the Beck Anxiety Scale (BAS), and the E-Health Literacy Scale as pre-test applications. The training program prepared for the experimental group will be presented. Final tests will be conducted at the end of the training. Individuals will be contacted by phone one month after the training for reminder purposes. Individuals are expected to participate in cancer screening within 3 months.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2025
Actual (reported)January 1, 2026
Actual (reported)June 11, 2026
Actual (reported)October 29, 2026
Actual (reported)January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
DATA COLLECTION
Michel Illness Uncertainty Scale-Community Form (IID-T): The scale is evaluated based on three sub-dimensions: "perception of current situation," "perception of understanding," and "uncertainty," and a total score. The scale score is obtained by summing the points given to each item. The possible score ranges from 20 to 100. A higher score indicates increased illness uncertainty.
about 3 months from the initial stage
DATA COLLECTION
Cancer Fear Scale (CFS): This scale consists of 17 items and 2 sub-dimensions: direct fear and indirect fear. The possible total score ranges from 0 to 68. Higher scores indicate a higher level of cancer fear.
about 3 months from the initial stage
DATA COLLECTION
e-Health Literacy Scale (e-Health Literacy): This scale consists of eight items measuring internet attitudes, two of which assess internet use. The lowest possible score is 8, and the highest is 40. A high score indicates a high level of e-health literacy.
about 3 months from the initial stage
The data for the study were collected at Merzifon Kara Mustafa Paşa State Hospital in Merzifon district of Amasya province, and were completed with 44 individuals in the experimental group and 44 individuals in the control group who met the inclusion criteria. In the study, all individuals in the sample group were administered the Personal Information Form, the Mishel Illness Uncertainty Scale-Community Form (MIIS-T), the Beck Anxiety Scale (BAS), and the E-Health Literacy Scale as pre-test applications. The Personal Information Form, Michel Illness Uncertainty Scale-Community Form (MIIS-T), Beck Anxiety Scale (BAS), and E-Health Literacy Scale were administered to individuals diagnosed with stroke in the experimental group.
Following the completion of the data collection process, participants in the control group will receive the same training through home visits and will be given the training booklet. This practice aims to ensure that participants in the control group also benefit from the training, as an ethical requirement.
During home visits, written informed consent will be obtained, the study protocol will be explained, and pre-tests will be administered. Individuals who undergo the pre-test will be randomly assigned to experimental and control groups using a simple random sampling method. The experimental group will receive the planned training, and a training booklet will be provided at the end of the training. One month after the completion of the training, individuals will be visited again at their homes to remind them of their participation in the cancer screening program, and post-tests will be administered. Three months after the start of the study, statements will be obtained from the phone numbers on the patient list to determine whether the experimental group participated in cancer screenings.
Merzifon Kara Mustafa Paşa Devlet Hastanesi
Amasya, Merzi̇fon, 05300, Turkey (Türkiye)
İLKNUR A AVCI, PROF
ONDOKUZ MAY UNIVERSTY
88 participants (actual enrollment reported by the registry).
First Submitted
June 11, 2026
First Posted
October 29, 2026
Study Start
January 1, 2025
Actual (reported)The Effects of Augmented Reality Versus Virtual Reality
Contact the study team to confirm eligibility.
Primary Completion
January 1, 2026
Actual (reported)Study Completion
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 29, 2026
Record last verified: 2026-10
Individual patient data is not shared in order to protect the individual's privacy and avoid legal repercussions.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: